Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. macular degeneration
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Asia & Middle East
  • Australasia
  • North America
Brands

  • medchemexpress
  • adaptdx
  • clearside
  • ocugen
  • 3b scientific
View all brands
Applications

  • Medical cannabis solutions for regulatory pathway sector
  • Medical cannabis solutions for mental health costs sector

Macular Degeneration Equipment & Supplies

46 equipment items found

Dark Adaptation - Model AMD - Age-Related Macular Degeneration

Dark Adaptation - Model AMD - Age-Related Macular Degeneration

Manufactured by:Heru, Inc.   based inMiami, FLORIDA (USA)
Don’t let age-related macular degeneration (AMD) be your practice’s blind spot. Heru's Market-Leading AMD Portfolio. Heru’s AMD portfolio leverages contrast sensitivity & dark adaptation, which studies have shown may aid physicians in the detection of AMD-related changes up to three years before drusen are visible allowing for earlier ...
CONTACT SUPPLIER

Age-Related Macular Degeneration

Age-Related Macular Degeneration

Manufactured by:HEALIOS K.K.   based inTokyo, JAPAN
” In the center of the macula is the fovea, 1.5 to 2 mm in diameter, where light entering through the lens is focused, which functions most importantly for visual acuity. Therefore, if macular function is impaired, sufficient visual acuity cannot be obtained even when other regions of the retina are healthy. When an older person experiences vision problems because of an ...
CONTACT SUPPLIER

Ikarovec - Age-Related Macular Degeneration (AMD) Biotechnology

Ikarovec - Age-Related Macular Degeneration (AMD) Biotechnology

Manufactured by:Ikarovec   based inNorwich, UNITED KINGDOM
Age-related macular degeneration (AMD) is a painless eye condition that leads to the gradual loss of central vision and is the most common cause of sight loss in the developed world and the third most common globally. Around 600,000 people in the UK currently have sight loss caused by AMD and around 70,000 new cases are diagnosed every year. ...
CONTACT SUPPLIER

Reglagene - Model RGNXXXX - Age Related Macular Degeneration for Microtubule Targeting Agent

Reglagene - Model RGNXXXX - Age Related Macular Degeneration for Microtubule Targeting Agent

Manufactured by:Reglagene Holding, Inc.   based inTucson, ARIZONA (USA)
RGNXXXX is a potent, topical eye drop for the treatment of wet AMD. The anti-neovascular effects reduces leaky blood vessels in the ...
CONTACT SUPPLIER

OpRegen - Advanced Dry Age-Related Macular Degeneration (Dry AMD)

OpRegen - Advanced Dry Age-Related Macular Degeneration (Dry AMD)

Manufactured by:Lineage Cell Therapeutics, Inc.   based inCarlsbad, CALIFORNIA (USA)
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) ...
CONTACT SUPPLIER

AdAlta - i-body Technology Platform

AdAlta - i-body Technology Platform

by:AdAlta Limited   based inBundoora, AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
CONTACT SUPPLIER

Electrospinning - Retinal Pigment Epithelium

Electrospinning - Retinal Pigment Epithelium

Manufactured by:The Electrospinning Company Ltd.    based inDidcot, UNITED KINGDOM
The aim of this case study was to evaluate whether the Mimetix scaffold can mimic Bruch’s membrane and assess the attachment, proliferation and differentiation of human RPE cells (ARPE-19) cells within it as a treatment option for age-related macular degeneration. Age-related macular degeneration (AMD) is the most common ...
CONTACT SUPPLIER

Henlius - Model HLX04-O - Bevacizumab Injection

Henlius - Model HLX04-O - Bevacizumab Injection

Manufactured by:Shanghai Henlius Biotech, Inc   based inShanghai, CHINA
HLX04-O, recombinant anti-VEGF humanised monoclonal antibody injection. It is indicated for wet age-related macular degeneration (wAMD). HLX04-O was granted Phase 3 clinical study approvals in Australia, the United States, Singapore and the EU countries such as Latvia, Hungary and Spanish. In April 2022, the first patient in Australia and Latvia was dosed in the ...
CONTACT SUPPLIER

ForeseeHome - Home-Based Monitoring System

ForeseeHome - Home-Based Monitoring System

Manufactured by:Notal Vision, Inc.   based inManassas, VIRGINIA (USA)
A home-based monitoring program supporting earlier detection of wet AMD in intermediate dry AMD patients. FDA-Cleared and Covered by Medicare and Most Private Insurance. The progression from dry Age-related Macular Degeneration (AMD) to wet AMD can occur rapidly and lead to severe vision loss if left undiagnosed and untreated. ForeseeHome® allows physicians ...
CONTACT SUPPLIER

Ocugen - Model OCU410 - Modifier Gene Therapy Vaccine

Ocugen - Model OCU410 - Modifier Gene Therapy Vaccine

Manufactured by:Ocugen, Inc.   based inMalvern, PENNSYLVANIA (USA)
OCU410 (AAV-RORA) is a modifier gene therapy product candidate being developed for the treatment of dry age-related macular degeneration (Dry AMD). OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA (RAR Related Orphan Receptor A) gene. Various genes associated with AMD are regulated by RORA. The RORA protein plays an important role in ...
CONTACT SUPPLIER

MedChemExpress - Model Emixustat - 1141777-14-1

MedChemExpress - Model Emixustat - 1141777-14-1

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Emixustat is also a visual cycle modulator, capable of regulating visual cycle activity by inhibiting retinol isomerization, and holds potential for studying vision disorders such as age-related macular degeneration ...
CONTACT SUPPLIER

Notal - Model OCT - Computational Image Analyzer

Notal - Model OCT - Computational Image Analyzer

Manufactured by:Notal Vision, Inc.   based inManassas, VIRGINIA (USA)
The Notal OCT Analyzer (NOATM) is a computational image analysis algorithm designed to provide automated detection of fluid in exudative retinal diseases including wet Age-Related Macular Degeneration, macular edema, and retinal vein occlusions. NOA uses a machine learning algorithm and image recognition computational technique to distinguish ...
CONTACT SUPPLIER

Notal Home - Optical Coherence Tomography Analyzer (OCT)

Notal Home - Optical Coherence Tomography Analyzer (OCT)

Manufactured by:Notal Vision, Inc.   based inManassas, VIRGINIA (USA)
Notal Vision is developing a first-of-its-kind Artificial Intelligence-enabled digital diagnostic for patients with neovascular retina diseases using our patient-operated Home Optical Coherence Tomography device. The first disease in the Notal Home OCT Program pipeline is neovascular Age-related Macular Degeneration ...
CONTACT SUPPLIER

MedChemExpress - Model UBX1325 - 2271269-01-1

MedChemExpress - Model UBX1325 - 2271269-01-1

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy ...
CONTACT SUPPLIER

MedChemExpress - Model Aflibercept - 862111-32-8

MedChemExpress - Model Aflibercept - 862111-32-8

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular ...
CONTACT SUPPLIER

MedChemExpress - Model Emixustat hydrochloride - 1141934-97-5

MedChemExpress - Model Emixustat hydrochloride - 1141934-97-5

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Emixustat hydrochloride is also a visual cycle modulator, capable of regulating visual cycle activity by inhibiting retinol isomerization, and holds potential for studying vision disorders such as age-related macular degeneration ...
CONTACT SUPPLIER

MedChemExpress - Model Aflibercept - 862111-32-8

MedChemExpress - Model Aflibercept - 862111-32-8

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular ...
CONTACT SUPPLIER

MedChemExpress - Model Aflibercept (VEGF Trap) - 862111-32-8

MedChemExpress - Model Aflibercept (VEGF Trap) - 862111-32-8

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular ...
CONTACT SUPPLIER

Ocugen - Model OCU200 - Biologic Product

Ocugen - Model OCU200 - Biologic Product

Manufactured by:Ocugen, Inc.   based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as ...
CONTACT SUPPLIER

Kalaris - TH103 for Retinal Disease Treatment

Kalaris - TH103 for Retinal Disease Treatment

Manufactured by:Kalaris   based inWaltham, MASSACHUSETTS (USA)
With high affinity for VEGF and heparan sulfate proteoglycans, TH103 potentially increases intraocular retention, thereby minimizing injection frequency. Ongoing Phase 1 clinical trials for neovascular age-related macular degeneration (nAMD) explore its effectiveness, with future applications planned for other retinal diseases. The scientific foundation of TH103 ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT